46 Firms. 100 Years. Half of All Market Wealth | The Hidden Math of 100 Baggers
TL;DR
Just 46 companies generated half of all stock market wealth over the past century, demonstrating that extreme outliers drive returns and investors should study these rare '100-baggers' for identifiable traits rather than relying solely on statistical base rates that assume mean reversion.
📈 The Math of Extreme Outcomes 3 insights
46 firms dominated wealth creation
Hendrik Bessembinder's research shows only 46 stocks accounted for 50% of net wealth creation from 1926-2025 among 29,000 listings.
Most stocks lose money
The median stock returned negative 6.9% annually over the century, confirming that broad diversification captures more losers than winners.
Concentration captures outliers
Portfolio construction should prioritize 15-20 carefully selected names to maximize shots at extreme outcomes rather than indexing.
🎲 Base Rates vs. Survivorship Bias 3 insights
Clarifying research intent
Studying 100-baggers isn't survivorship bias because the goal is identifying traits of extreme winners (like Tiger Woods' swing), not statistically predicting future winners.
Mauboussin's foundation
Base rates represent the distribution of historical outcomes for similar situations, serving as the starting assumption before analyzing divergence potential.
Divergence is exceptional
While Michael Mauboussin notes that sustainably outperforming base rates is statistically rare, these rare exceptions generate all excess wealth.
🤖 AI and Historical Pattern Disruption 3 insights
Software base rate uncertainty
Robert Hagstrom exited most software positions because AI creates unquantifiable changes to long-term revenue growth rates and terminal values.
The residual value dilemma
AI threatens the terminal value that comprises 80% of software company valuations, making traditional discounted cash flow models unreliable.
Innovation cycle realities
Chris Mayer notes that while new technologies like AI appear to break historical rules initially, adoption typically takes longer and proves more disappointing than early hype suggests.
🔍 Inside View vs. Outside View 3 insights
Reconciling perspectives
Investors must balance deep company knowledge (inside view) with statistical base rates (outside view) by analyzing competitive advantages that sustain high returns.
Buffett's consistency filter
Rather than simple mean reversion, Buffett examines multi-decade operating histories to identify companies that motor through various economic cycles.
Circle of competence matters
Understanding whether market movements reflect temporary macro factors or lasting business changes determines if base rates remain valid.
Bottom Line
Build concentrated portfolios to capture rare extreme wealth creators while using base rates as a starting point, but remain willing to abandon historical patterns when structural disruptions like AI invalidate future growth assumptions.
More from Excess Returns
View all
The War No One Can Price | The Weekly Wrap – 3/22/2026
Markets often exhibit 'willful ignorance' toward obvious geopolitical threats like war until they materialize, while current options data shows a historic disconnect between implied volatility (VIX ~22) and realized volatility, indicating heavy hedging that could trigger sharp moves when protective positions expire.
A 3% Drop from VIX 40 | What the Options Market Tells Us About What Comes Next
Options markets are exhibiting unusual dynamics with VIX elevated at 25 despite low realized volatility, indicating investors are heavily hedged against 'known unknowns' like geopolitical risks. This creates a dangerous setup where the unwind of OPEX hedges could trigger sudden volatility expansion and sharp market drawdowns.
Down 50%. Up 200% | Jared Dillian on the Regime Change Investors Aren't Ready For
Jared Dillian argues markets structurally fail to price low-frequency, high-impact events due to 'willful ignorance,' while the post-2020 inflationary regime has broken the 60/40 portfolio by flipping stock-bond correlations positive, requiring investors to abandon outdated playbooks and embrace radical adaptability.
They Call It a Lottery Ticket. The Data Says Otherwise | The Hidden Alpha of Biotech
Biotech investing is not gambling but a systematic 'bag of options' exercise where specialist investors can generate persistent alpha by probability-weighting drug development pipelines, though the sector experiences violent capital cycles driven by interest rates and competition from technology narratives like AI.